StockData
Veracyte, Inc. logo

Veracyte, Inc. (VCYT) stock

VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.13+0.09 (+0.36%)

Close on Nov 20, 2026Market cap $2.02BP/E 17.9Yield –

Veracyte pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Veracyte's pe ratio was 17.9× on Nov 11, 2026, against 124.6× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202617.9×−92.9
2025Dec 31, 2025110.8×–

More Veracyte figures

See a number that looks wrong?